nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A1—hematologic cancer	0.416	1	CbGaD
Ganciclovir—SLC22A1—Cytarabine—hematologic cancer	0.0626	0.216	CbGbCtD
Ganciclovir—SLC22A1—Cladribine—hematologic cancer	0.0591	0.204	CbGbCtD
Ganciclovir—SLC22A1—Imatinib—hematologic cancer	0.0544	0.188	CbGbCtD
Ganciclovir—SLC22A8—Mercaptopurine—hematologic cancer	0.0543	0.187	CbGbCtD
Ganciclovir—SLC22A7—Methotrexate—hematologic cancer	0.0291	0.1	CbGbCtD
Ganciclovir—SLC22A8—Methotrexate—hematologic cancer	0.0177	0.0613	CbGbCtD
Ganciclovir—SLC22A6—Methotrexate—hematologic cancer	0.0124	0.0427	CbGbCtD
Ganciclovir—Aciclovir—SLC22A1—hematologic cancer	0.000789	1	CrCbGaD
Ganciclovir—Vision blurred—Methotrexate—hematologic cancer	1.57e-05	5.36e-05	CcSEcCtD
Ganciclovir—Mental disorder—Epirubicin—hematologic cancer	1.57e-05	5.36e-05	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—hematologic cancer	1.57e-05	5.35e-05	CcSEcCtD
Ganciclovir—Rash—Cisplatin—hematologic cancer	1.57e-05	5.33e-05	CcSEcCtD
Ganciclovir—Dermatitis—Cisplatin—hematologic cancer	1.56e-05	5.33e-05	CcSEcCtD
Ganciclovir—Malnutrition—Epirubicin—hematologic cancer	1.56e-05	5.32e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Etoposide—hematologic cancer	1.56e-05	5.3e-05	CcSEcCtD
Ganciclovir—Anorexia—Prednisone—hematologic cancer	1.55e-05	5.29e-05	CcSEcCtD
Ganciclovir—Ill-defined disorder—Methotrexate—hematologic cancer	1.55e-05	5.28e-05	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—hematologic cancer	1.55e-05	5.27e-05	CcSEcCtD
Ganciclovir—Anaemia—Methotrexate—hematologic cancer	1.54e-05	5.26e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Dexamethasone—hematologic cancer	1.54e-05	5.25e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Betamethasone—hematologic cancer	1.54e-05	5.25e-05	CcSEcCtD
Ganciclovir—Flatulence—Epirubicin—hematologic cancer	1.54e-05	5.24e-05	CcSEcCtD
Ganciclovir—Tension—Epirubicin—hematologic cancer	1.53e-05	5.22e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Betamethasone—hematologic cancer	1.53e-05	5.21e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.53e-05	5.21e-05	CcSEcCtD
Ganciclovir—Dysgeusia—Epirubicin—hematologic cancer	1.53e-05	5.21e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Triamcinolone—hematologic cancer	1.52e-05	5.18e-05	CcSEcCtD
Ganciclovir—Nervousness—Epirubicin—hematologic cancer	1.52e-05	5.17e-05	CcSEcCtD
Ganciclovir—Back pain—Epirubicin—hematologic cancer	1.51e-05	5.15e-05	CcSEcCtD
Ganciclovir—Angiopathy—Doxorubicin—hematologic cancer	1.51e-05	5.13e-05	CcSEcCtD
Ganciclovir—Malaise—Methotrexate—hematologic cancer	1.51e-05	5.13e-05	CcSEcCtD
Ganciclovir—Dizziness—Etoposide—hematologic cancer	1.5e-05	5.12e-05	CcSEcCtD
Ganciclovir—Muscle spasms—Epirubicin—hematologic cancer	1.5e-05	5.12e-05	CcSEcCtD
Ganciclovir—Vertigo—Methotrexate—hematologic cancer	1.5e-05	5.11e-05	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—hematologic cancer	1.5e-05	5.1e-05	CcSEcCtD
Ganciclovir—Leukopenia—Methotrexate—hematologic cancer	1.49e-05	5.09e-05	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—hematologic cancer	1.49e-05	5.07e-05	CcSEcCtD
Ganciclovir—Urticaria—Dexamethasone—hematologic cancer	1.49e-05	5.07e-05	CcSEcCtD
Ganciclovir—Urticaria—Betamethasone—hematologic cancer	1.49e-05	5.07e-05	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.49e-05	5.06e-05	CcSEcCtD
Ganciclovir—Dizziness—Prednisolone—hematologic cancer	1.48e-05	5.05e-05	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—hematologic cancer	1.48e-05	5.05e-05	CcSEcCtD
Ganciclovir—Asthenia—Triamcinolone—hematologic cancer	1.48e-05	5.04e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Dexamethasone—hematologic cancer	1.48e-05	5.04e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Dexamethasone—hematologic cancer	1.48e-05	5.04e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Betamethasone—hematologic cancer	1.48e-05	5.04e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Betamethasone—hematologic cancer	1.48e-05	5.04e-05	CcSEcCtD
Ganciclovir—Nausea—Cisplatin—hematologic cancer	1.47e-05	5.02e-05	CcSEcCtD
Ganciclovir—Insomnia—Prednisone—hematologic cancer	1.47e-05	5.02e-05	CcSEcCtD
Ganciclovir—Vision blurred—Epirubicin—hematologic cancer	1.47e-05	5.01e-05	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—hematologic cancer	1.47e-05	5e-05	CcSEcCtD
Ganciclovir—Paraesthesia—Prednisone—hematologic cancer	1.46e-05	4.99e-05	CcSEcCtD
Ganciclovir—Pruritus—Triamcinolone—hematologic cancer	1.46e-05	4.97e-05	CcSEcCtD
Ganciclovir—Cough—Methotrexate—hematologic cancer	1.46e-05	4.96e-05	CcSEcCtD
Ganciclovir—Mental disorder—Doxorubicin—hematologic cancer	1.45e-05	4.95e-05	CcSEcCtD
Ganciclovir—Ill-defined disorder—Epirubicin—hematologic cancer	1.45e-05	4.94e-05	CcSEcCtD
Ganciclovir—Convulsion—Methotrexate—hematologic cancer	1.45e-05	4.93e-05	CcSEcCtD
Ganciclovir—Vomiting—Etoposide—hematologic cancer	1.45e-05	4.93e-05	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—hematologic cancer	1.45e-05	4.92e-05	CcSEcCtD
Ganciclovir—Anaemia—Epirubicin—hematologic cancer	1.44e-05	4.92e-05	CcSEcCtD
Ganciclovir—Agitation—Epirubicin—hematologic cancer	1.44e-05	4.89e-05	CcSEcCtD
Ganciclovir—Dyspepsia—Prednisone—hematologic cancer	1.43e-05	4.89e-05	CcSEcCtD
Ganciclovir—Rash—Etoposide—hematologic cancer	1.43e-05	4.88e-05	CcSEcCtD
Ganciclovir—Dermatitis—Etoposide—hematologic cancer	1.43e-05	4.88e-05	CcSEcCtD
Ganciclovir—Headache—Etoposide—hematologic cancer	1.42e-05	4.85e-05	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—hematologic cancer	1.42e-05	4.85e-05	CcSEcCtD
Ganciclovir—Chest pain—Methotrexate—hematologic cancer	1.42e-05	4.84e-05	CcSEcCtD
Ganciclovir—Myalgia—Methotrexate—hematologic cancer	1.42e-05	4.84e-05	CcSEcCtD
Ganciclovir—Arthralgia—Methotrexate—hematologic cancer	1.42e-05	4.84e-05	CcSEcCtD
Ganciclovir—Tension—Doxorubicin—hematologic cancer	1.42e-05	4.83e-05	CcSEcCtD
Ganciclovir—Decreased appetite—Prednisone—hematologic cancer	1.42e-05	4.83e-05	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—hematologic cancer	1.42e-05	4.82e-05	CcSEcCtD
Ganciclovir—Rash—Prednisolone—hematologic cancer	1.41e-05	4.82e-05	CcSEcCtD
Ganciclovir—Dermatitis—Prednisolone—hematologic cancer	1.41e-05	4.81e-05	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.41e-05	4.81e-05	CcSEcCtD
Ganciclovir—Malaise—Epirubicin—hematologic cancer	1.41e-05	4.8e-05	CcSEcCtD
Ganciclovir—Fatigue—Prednisone—hematologic cancer	1.41e-05	4.79e-05	CcSEcCtD
Ganciclovir—Headache—Prednisolone—hematologic cancer	1.41e-05	4.79e-05	CcSEcCtD
Ganciclovir—Discomfort—Methotrexate—hematologic cancer	1.4e-05	4.78e-05	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—hematologic cancer	1.4e-05	4.78e-05	CcSEcCtD
Ganciclovir—Vertigo—Epirubicin—hematologic cancer	1.4e-05	4.78e-05	CcSEcCtD
Ganciclovir—Leukopenia—Epirubicin—hematologic cancer	1.4e-05	4.76e-05	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—hematologic cancer	1.4e-05	4.76e-05	CcSEcCtD
Ganciclovir—Constipation—Prednisone—hematologic cancer	1.39e-05	4.75e-05	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—hematologic cancer	1.39e-05	4.73e-05	CcSEcCtD
Ganciclovir—Confusional state—Methotrexate—hematologic cancer	1.37e-05	4.68e-05	CcSEcCtD
Ganciclovir—Dizziness—Triamcinolone—hematologic cancer	1.36e-05	4.65e-05	CcSEcCtD
Ganciclovir—Cough—Epirubicin—hematologic cancer	1.36e-05	4.64e-05	CcSEcCtD
Ganciclovir—Anaphylactic shock—Methotrexate—hematologic cancer	1.36e-05	4.64e-05	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—hematologic cancer	1.36e-05	4.64e-05	CcSEcCtD
Ganciclovir—Convulsion—Epirubicin—hematologic cancer	1.35e-05	4.61e-05	CcSEcCtD
Ganciclovir—Infection—Methotrexate—hematologic cancer	1.35e-05	4.61e-05	CcSEcCtD
Ganciclovir—Nausea—Etoposide—hematologic cancer	1.35e-05	4.6e-05	CcSEcCtD
Ganciclovir—Hypertension—Epirubicin—hematologic cancer	1.35e-05	4.59e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Prednisone—hematologic cancer	1.34e-05	4.58e-05	CcSEcCtD
Ganciclovir—Asthenia—Dexamethasone—hematologic cancer	1.34e-05	4.57e-05	CcSEcCtD
Ganciclovir—Asthenia—Betamethasone—hematologic cancer	1.34e-05	4.57e-05	CcSEcCtD
Ganciclovir—Ill-defined disorder—Doxorubicin—hematologic cancer	1.34e-05	4.57e-05	CcSEcCtD
Ganciclovir—Anaemia—Doxorubicin—hematologic cancer	1.34e-05	4.55e-05	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methotrexate—hematologic cancer	1.33e-05	4.54e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Prednisone—hematologic cancer	1.33e-05	4.54e-05	CcSEcCtD
Ganciclovir—Nausea—Prednisolone—hematologic cancer	1.33e-05	4.54e-05	CcSEcCtD
Ganciclovir—Myalgia—Epirubicin—hematologic cancer	1.33e-05	4.53e-05	CcSEcCtD
Ganciclovir—Arthralgia—Epirubicin—hematologic cancer	1.33e-05	4.53e-05	CcSEcCtD
Ganciclovir—Chest pain—Epirubicin—hematologic cancer	1.33e-05	4.53e-05	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—hematologic cancer	1.33e-05	4.52e-05	CcSEcCtD
Ganciclovir—Anxiety—Epirubicin—hematologic cancer	1.33e-05	4.51e-05	CcSEcCtD
Ganciclovir—Pruritus—Betamethasone—hematologic cancer	1.32e-05	4.51e-05	CcSEcCtD
Ganciclovir—Pruritus—Dexamethasone—hematologic cancer	1.32e-05	4.51e-05	CcSEcCtD
Ganciclovir—Skin disorder—Methotrexate—hematologic cancer	1.32e-05	4.51e-05	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.32e-05	4.5e-05	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methotrexate—hematologic cancer	1.32e-05	4.49e-05	CcSEcCtD
Ganciclovir—Discomfort—Epirubicin—hematologic cancer	1.31e-05	4.48e-05	CcSEcCtD
Ganciclovir—Vomiting—Triamcinolone—hematologic cancer	1.31e-05	4.47e-05	CcSEcCtD
Ganciclovir—Malaise—Doxorubicin—hematologic cancer	1.3e-05	4.44e-05	CcSEcCtD
Ganciclovir—Rash—Triamcinolone—hematologic cancer	1.3e-05	4.43e-05	CcSEcCtD
Ganciclovir—Dry mouth—Epirubicin—hematologic cancer	1.3e-05	4.43e-05	CcSEcCtD
Ganciclovir—Dermatitis—Triamcinolone—hematologic cancer	1.3e-05	4.43e-05	CcSEcCtD
Ganciclovir—Vertigo—Doxorubicin—hematologic cancer	1.3e-05	4.42e-05	CcSEcCtD
Ganciclovir—Anorexia—Methotrexate—hematologic cancer	1.3e-05	4.42e-05	CcSEcCtD
Ganciclovir—Urticaria—Prednisone—hematologic cancer	1.29e-05	4.41e-05	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—hematologic cancer	1.29e-05	4.41e-05	CcSEcCtD
Ganciclovir—Headache—Triamcinolone—hematologic cancer	1.29e-05	4.4e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Prednisone—hematologic cancer	1.29e-05	4.39e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Prednisone—hematologic cancer	1.29e-05	4.39e-05	CcSEcCtD
Ganciclovir—Confusional state—Epirubicin—hematologic cancer	1.29e-05	4.38e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Dexamethasone—hematologic cancer	1.28e-05	4.36e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Betamethasone—hematologic cancer	1.28e-05	4.36e-05	CcSEcCtD
Ganciclovir—Anaphylactic shock—Epirubicin—hematologic cancer	1.27e-05	4.34e-05	CcSEcCtD
Ganciclovir—Oedema—Epirubicin—hematologic cancer	1.27e-05	4.34e-05	CcSEcCtD
Ganciclovir—Hypotension—Methotrexate—hematologic cancer	1.27e-05	4.34e-05	CcSEcCtD
Ganciclovir—Infection—Epirubicin—hematologic cancer	1.27e-05	4.31e-05	CcSEcCtD
Ganciclovir—Cough—Doxorubicin—hematologic cancer	1.26e-05	4.3e-05	CcSEcCtD
Ganciclovir—Convulsion—Doxorubicin—hematologic cancer	1.25e-05	4.27e-05	CcSEcCtD
Ganciclovir—Thrombocytopenia—Epirubicin—hematologic cancer	1.25e-05	4.25e-05	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—hematologic cancer	1.25e-05	4.25e-05	CcSEcCtD
Ganciclovir—Tachycardia—Epirubicin—hematologic cancer	1.24e-05	4.24e-05	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.24e-05	4.23e-05	CcSEcCtD
Ganciclovir—Skin disorder—Epirubicin—hematologic cancer	1.24e-05	4.22e-05	CcSEcCtD
Ganciclovir—Dizziness—Dexamethasone—hematologic cancer	1.24e-05	4.22e-05	CcSEcCtD
Ganciclovir—Dizziness—Betamethasone—hematologic cancer	1.24e-05	4.22e-05	CcSEcCtD
Ganciclovir—Hyperhidrosis—Epirubicin—hematologic cancer	1.23e-05	4.2e-05	CcSEcCtD
Ganciclovir—Insomnia—Methotrexate—hematologic cancer	1.23e-05	4.2e-05	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—hematologic cancer	1.23e-05	4.19e-05	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—hematologic cancer	1.23e-05	4.19e-05	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—hematologic cancer	1.23e-05	4.19e-05	CcSEcCtD
Ganciclovir—Anxiety—Doxorubicin—hematologic cancer	1.23e-05	4.18e-05	CcSEcCtD
Ganciclovir—Nausea—Triamcinolone—hematologic cancer	1.23e-05	4.17e-05	CcSEcCtD
Ganciclovir—Paraesthesia—Methotrexate—hematologic cancer	1.22e-05	4.17e-05	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.22e-05	4.16e-05	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—hematologic cancer	1.22e-05	4.14e-05	CcSEcCtD
Ganciclovir—Anorexia—Epirubicin—hematologic cancer	1.22e-05	4.14e-05	CcSEcCtD
Ganciclovir—Dyspnoea—Methotrexate—hematologic cancer	1.21e-05	4.14e-05	CcSEcCtD
Ganciclovir—Somnolence—Methotrexate—hematologic cancer	1.21e-05	4.13e-05	CcSEcCtD
Ganciclovir—Dry mouth—Doxorubicin—hematologic cancer	1.2e-05	4.1e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Prednisone—hematologic cancer	1.2e-05	4.09e-05	CcSEcCtD
Ganciclovir—Dyspepsia—Methotrexate—hematologic cancer	1.2e-05	4.08e-05	CcSEcCtD
Ganciclovir—Hypotension—Epirubicin—hematologic cancer	1.19e-05	4.06e-05	CcSEcCtD
Ganciclovir—Vomiting—Betamethasone—hematologic cancer	1.19e-05	4.05e-05	CcSEcCtD
Ganciclovir—Vomiting—Dexamethasone—hematologic cancer	1.19e-05	4.05e-05	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—hematologic cancer	1.19e-05	4.05e-05	CcSEcCtD
Ganciclovir—Decreased appetite—Methotrexate—hematologic cancer	1.18e-05	4.03e-05	CcSEcCtD
Ganciclovir—Rash—Dexamethasone—hematologic cancer	1.18e-05	4.02e-05	CcSEcCtD
Ganciclovir—Rash—Betamethasone—hematologic cancer	1.18e-05	4.02e-05	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—hematologic cancer	1.18e-05	4.02e-05	CcSEcCtD
Ganciclovir—Oedema—Doxorubicin—hematologic cancer	1.18e-05	4.02e-05	CcSEcCtD
Ganciclovir—Dermatitis—Dexamethasone—hematologic cancer	1.18e-05	4.02e-05	CcSEcCtD
Ganciclovir—Dermatitis—Betamethasone—hematologic cancer	1.18e-05	4.02e-05	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.18e-05	4.01e-05	CcSEcCtD
Ganciclovir—Fatigue—Methotrexate—hematologic cancer	1.17e-05	4e-05	CcSEcCtD
Ganciclovir—Headache—Dexamethasone—hematologic cancer	1.17e-05	3.99e-05	CcSEcCtD
Ganciclovir—Headache—Betamethasone—hematologic cancer	1.17e-05	3.99e-05	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—hematologic cancer	1.17e-05	3.99e-05	CcSEcCtD
Ganciclovir—Asthenia—Prednisone—hematologic cancer	1.17e-05	3.98e-05	CcSEcCtD
Ganciclovir—Pain—Methotrexate—hematologic cancer	1.16e-05	3.97e-05	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.16e-05	3.96e-05	CcSEcCtD
Ganciclovir—Thrombocytopenia—Doxorubicin—hematologic cancer	1.15e-05	3.93e-05	CcSEcCtD
Ganciclovir—Pruritus—Prednisone—hematologic cancer	1.15e-05	3.93e-05	CcSEcCtD
Ganciclovir—Insomnia—Epirubicin—hematologic cancer	1.15e-05	3.93e-05	CcSEcCtD
Ganciclovir—Tachycardia—Doxorubicin—hematologic cancer	1.15e-05	3.92e-05	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—hematologic cancer	1.15e-05	3.9e-05	CcSEcCtD
Ganciclovir—Paraesthesia—Epirubicin—hematologic cancer	1.14e-05	3.9e-05	CcSEcCtD
Ganciclovir—Hyperhidrosis—Doxorubicin—hematologic cancer	1.14e-05	3.88e-05	CcSEcCtD
Ganciclovir—Dyspnoea—Epirubicin—hematologic cancer	1.14e-05	3.87e-05	CcSEcCtD
Ganciclovir—Somnolence—Epirubicin—hematologic cancer	1.13e-05	3.86e-05	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—hematologic cancer	1.12e-05	3.83e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Methotrexate—hematologic cancer	1.12e-05	3.82e-05	CcSEcCtD
Ganciclovir—Dyspepsia—Epirubicin—hematologic cancer	1.12e-05	3.82e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Prednisone—hematologic cancer	1.12e-05	3.8e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Methotrexate—hematologic cancer	1.11e-05	3.79e-05	CcSEcCtD
Ganciclovir—Nausea—Betamethasone—hematologic cancer	1.11e-05	3.79e-05	CcSEcCtD
Ganciclovir—Nausea—Dexamethasone—hematologic cancer	1.11e-05	3.79e-05	CcSEcCtD
Ganciclovir—Decreased appetite—Epirubicin—hematologic cancer	1.11e-05	3.78e-05	CcSEcCtD
Ganciclovir—Hypotension—Doxorubicin—hematologic cancer	1.1e-05	3.75e-05	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.1e-05	3.75e-05	CcSEcCtD
Ganciclovir—Fatigue—Epirubicin—hematologic cancer	1.1e-05	3.74e-05	CcSEcCtD
Ganciclovir—Pain—Epirubicin—hematologic cancer	1.09e-05	3.71e-05	CcSEcCtD
Ganciclovir—Constipation—Epirubicin—hematologic cancer	1.09e-05	3.71e-05	CcSEcCtD
Ganciclovir—Urticaria—Methotrexate—hematologic cancer	1.08e-05	3.69e-05	CcSEcCtD
Ganciclovir—Dizziness—Prednisone—hematologic cancer	1.08e-05	3.67e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Methotrexate—hematologic cancer	1.08e-05	3.67e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Methotrexate—hematologic cancer	1.08e-05	3.67e-05	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.07e-05	3.66e-05	CcSEcCtD
Ganciclovir—Insomnia—Doxorubicin—hematologic cancer	1.07e-05	3.63e-05	CcSEcCtD
Ganciclovir—Paraesthesia—Doxorubicin—hematologic cancer	1.06e-05	3.61e-05	CcSEcCtD
Ganciclovir—Dyspnoea—Doxorubicin—hematologic cancer	1.05e-05	3.58e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Epirubicin—hematologic cancer	1.05e-05	3.58e-05	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—hematologic cancer	1.05e-05	3.57e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Epirubicin—hematologic cancer	1.04e-05	3.55e-05	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—hematologic cancer	1.04e-05	3.54e-05	CcSEcCtD
Ganciclovir—Vomiting—Prednisone—hematologic cancer	1.04e-05	3.53e-05	CcSEcCtD
Ganciclovir—Rash—Prednisone—hematologic cancer	1.03e-05	3.5e-05	CcSEcCtD
Ganciclovir—Dermatitis—Prednisone—hematologic cancer	1.03e-05	3.5e-05	CcSEcCtD
Ganciclovir—Decreased appetite—Doxorubicin—hematologic cancer	1.03e-05	3.49e-05	CcSEcCtD
Ganciclovir—Headache—Prednisone—hematologic cancer	1.02e-05	3.48e-05	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.02e-05	3.47e-05	CcSEcCtD
Ganciclovir—Fatigue—Doxorubicin—hematologic cancer	1.02e-05	3.46e-05	CcSEcCtD
Ganciclovir—Urticaria—Epirubicin—hematologic cancer	1.01e-05	3.45e-05	CcSEcCtD
Ganciclovir—Pain—Doxorubicin—hematologic cancer	1.01e-05	3.44e-05	CcSEcCtD
Ganciclovir—Constipation—Doxorubicin—hematologic cancer	1.01e-05	3.44e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Epirubicin—hematologic cancer	1.01e-05	3.43e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Epirubicin—hematologic cancer	1.01e-05	3.43e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Methotrexate—hematologic cancer	1e-05	3.42e-05	CcSEcCtD
Ganciclovir—Asthenia—Methotrexate—hematologic cancer	9.77e-06	3.33e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Doxorubicin—hematologic cancer	9.72e-06	3.31e-05	CcSEcCtD
Ganciclovir—Nausea—Prednisone—hematologic cancer	9.68e-06	3.3e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.65e-06	3.29e-05	CcSEcCtD
Ganciclovir—Pruritus—Methotrexate—hematologic cancer	9.64e-06	3.28e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Epirubicin—hematologic cancer	9.39e-06	3.2e-05	CcSEcCtD
Ganciclovir—Urticaria—Doxorubicin—hematologic cancer	9.37e-06	3.19e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—hematologic cancer	9.32e-06	3.18e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Doxorubicin—hematologic cancer	9.32e-06	3.18e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Methotrexate—hematologic cancer	9.32e-06	3.17e-05	CcSEcCtD
Ganciclovir—Asthenia—Epirubicin—hematologic cancer	9.15e-06	3.12e-05	CcSEcCtD
Ganciclovir—Pruritus—Epirubicin—hematologic cancer	9.02e-06	3.07e-05	CcSEcCtD
Ganciclovir—Dizziness—Methotrexate—hematologic cancer	9.01e-06	3.07e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Epirubicin—hematologic cancer	8.72e-06	2.97e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Doxorubicin—hematologic cancer	8.69e-06	2.96e-05	CcSEcCtD
Ganciclovir—Vomiting—Methotrexate—hematologic cancer	8.66e-06	2.95e-05	CcSEcCtD
Ganciclovir—Rash—Methotrexate—hematologic cancer	8.59e-06	2.93e-05	CcSEcCtD
Ganciclovir—Dermatitis—Methotrexate—hematologic cancer	8.58e-06	2.92e-05	CcSEcCtD
Ganciclovir—Headache—Methotrexate—hematologic cancer	8.53e-06	2.91e-05	CcSEcCtD
Ganciclovir—Asthenia—Doxorubicin—hematologic cancer	8.46e-06	2.88e-05	CcSEcCtD
Ganciclovir—Dizziness—Epirubicin—hematologic cancer	8.43e-06	2.87e-05	CcSEcCtD
Ganciclovir—Pruritus—Doxorubicin—hematologic cancer	8.35e-06	2.84e-05	CcSEcCtD
Ganciclovir—Vomiting—Epirubicin—hematologic cancer	8.11e-06	2.76e-05	CcSEcCtD
Ganciclovir—Nausea—Methotrexate—hematologic cancer	8.09e-06	2.76e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—hematologic cancer	8.07e-06	2.75e-05	CcSEcCtD
Ganciclovir—Rash—Epirubicin—hematologic cancer	8.04e-06	2.74e-05	CcSEcCtD
Ganciclovir—Dermatitis—Epirubicin—hematologic cancer	8.03e-06	2.74e-05	CcSEcCtD
Ganciclovir—Headache—Epirubicin—hematologic cancer	7.99e-06	2.72e-05	CcSEcCtD
Ganciclovir—Dizziness—Doxorubicin—hematologic cancer	7.8e-06	2.66e-05	CcSEcCtD
Ganciclovir—Nausea—Epirubicin—hematologic cancer	7.57e-06	2.58e-05	CcSEcCtD
Ganciclovir—Vomiting—Doxorubicin—hematologic cancer	7.5e-06	2.55e-05	CcSEcCtD
Ganciclovir—Rash—Doxorubicin—hematologic cancer	7.44e-06	2.53e-05	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—hematologic cancer	7.43e-06	2.53e-05	CcSEcCtD
Ganciclovir—Headache—Doxorubicin—hematologic cancer	7.39e-06	2.52e-05	CcSEcCtD
Ganciclovir—Nausea—Doxorubicin—hematologic cancer	7.01e-06	2.39e-05	CcSEcCtD
